Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more
Market Cap & Net Worth: Oaktree Acquisition Corp. III Life Sciences Unit (OACCU)
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ:OACCU) has a market capitalization of $100.32K ($100.32K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15155 globally and #5997 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oaktree Acquisition Corp. III Life Sciences Unit's stock price $10.68 by its total outstanding shares 9393 (9.39K).
Oaktree Acquisition Corp. III Life Sciences Unit Market Cap History: 2024 to 2026
Oaktree Acquisition Corp. III Life Sciences Unit's market capitalization history from 2024 to 2026. Data shows growth from $95.25K to $100.32K (0.00% CAGR).
Oaktree Acquisition Corp. III Life Sciences Unit Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oaktree Acquisition Corp. III Life Sciences Unit's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OACCU by Market Capitalization
Companies near Oaktree Acquisition Corp. III Life Sciences Unit in the global market cap rankings as of March 18, 2026.
Key companies related to Oaktree Acquisition Corp. III Life Sciences Unit by market ranking:
- CLUS (PINK:CLUS): Ranked #1961 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8548 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10601 globally with a market cap of $466.44 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1961 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8548 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩29800.00 |
| #10601 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $466.44 Million | $10.09 |
Oaktree Acquisition Corp. III Life Sciences Unit Historical Marketcap From 2024 to 2026
Between 2024 and today, Oaktree Acquisition Corp. III Life Sciences Unit's market cap moved from $95.25K to $ 100.32K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $100.32K | -0.28% |
| 2025 | $100.60K | +5.62% |
| 2024 | $95.25K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Oaktree Acquisition Corp. III Life Sciences Unit was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.32K USD |
| MoneyControl | $100.32K USD |
| MarketWatch | $100.32K USD |
| marketcap.company | $100.32K USD |
| Reuters | $100.32K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.